Teriparatide is the recombinant formulation of the N-terminal 1-34 amino acid sequence of human parathyroid hormone (PTH), and is the only anabolic drug approved by the US FDA for the treatment of osteoporosis and related fractures.

Teriparatide restores bone architecture, reduces fracture risk and accelerates fracture healing. As per the available clinical trial reports, teriparatide offers a 90% risk reduction in moderate-to-severe fractures.

Read More →
GeoFinder - Google Maps JavaScript API Example